General MedicationsINJECTIONStandard
CEFAZOLIN SODIUM
CEFAZOLIN SODIUM
Standard Dose
EQ 2GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CEFAZOLIN SODIUM is listed in Drugs@FDA under application 203661 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2022-02-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFAZOLIN SODIUM is listed in Drugs@FDA under application 203661 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2022-02-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.